Curated summary · agent-written · kb/genes/curated/hgnc_1122.md
All 13 claims checked against the KB draft

BTD across dismech

BTD (biotinidase) is named by 1 disorder entry, Biotinidase Deficiency.

Normal function

ai-gene-review gives BTD's core molecular function as biotinidase activity, acting in biotin metabolic process. Biotinidase releases free biotin from biocytin and biotinyl peptides so that the vitamin can be reused by the biotin-dependent carboxylases.

Causative record

Biotinidase Deficiency types BTD as causative, with a germline variant origin. The gene sits on the node Impaired biotin recycling. ClinGen rates the relationship definitive.

Agreement between the layers

The KB mechanism and the ai-gene-review core function share biotin metabolic process, so the process the disease entry marks as disrupted is the one the gene review gives as BTD's normal role.

ClinGen also classifies BTD for other diseases (2 in total). The dismech entries matched to those assertions that do not type BTD are Leber-like Hereditary Optic Neuropathy, Autosomal Recessive 1; and Leigh Syndrome; whether BTD belongs in those entries is a question for their curators, not a gap this page can close.

Underlined values are claims re-computed from the knowledge base each time this page is built. The tables below are the source of truth.

Normal function · from ai-gene-review (P43251, commit 79fe13b38970) · AI-generated, not KB evidence

ai-gene-review has this gene at status INITIALIZED; the description is shown only once the review is complete. Read the draft upstream.

In the knowledge base · computed from kb/ at build time

Disorders

Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.

DisorderRelationshipWhere the gene appears
Biotinidase Deficiency causative germline
CLINGEN: definitive
mechanism: Impaired biotin recycling
ClinGen gene–disease validity · snapshot 2026-10-03 · matched to entries by MONDO

An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.

ClinGen diseaseMOIClassificationdismech entry
biotinidase deficiency MONDO:0009665 AR Definitive
2020-02-10
Leigh syndrome MONDO:0009723 AR Moderate
2021-06-14
Leigh Syndrome not named

Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.